SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-21-005391
Filing Date
2021-04-30
Accepted
2021-04-30 16:01:05
Documents
4
Period of Report
2021-06-16

Document Format Files

Seq Description Document Type Size
1 DEF 14A tmb-20210616xdef14a.htm DEF 14A 876561
2 GRAPHIC tmb-20210616xdef14a001.jpg GRAPHIC 5399
3 GRAPHIC tmb-20210616xdef14a012.jpg GRAPHIC 91175
4 GRAPHIC tmb-20210616xdef14a011.jpg GRAPHIC 123971
  Complete submission text file 0001558370-21-005391.txt   1181981
Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-32639 | Film No.: 21877642
SIC: 2834 Pharmaceutical Preparations